We acknowledge and value gender diversity in our community. Please take the time to read our inclusive language statement here. In certain circumstances, extended access to CGM products through the NDSS may be granted for women and other people with type 1 diabetes who are actively planning pregnancy. Women with type 1 diabetes who are actively planning pregnancy Women with type 1 diabetes actively planning pregnancy are eligible for access to fully subsidised CGM products for a period up to 12 months (initial period of 6 months with a subsequent period of an additional 6 months on confirmation—by an authorised health professional—that pre-pregnancy care is continuing). Sometimes pregnancy planning may need to continue after the initial 12 months. Women are advised by the NDSS eight weeks before the end of the initial 12-month period that access to fully subsidised CGM products is coming to an end. When they no longer meet these criteria, women can continue to access fully subsidised products if they have valid concessional status. If they do not have valid concessional status, they will commence paying a co-payment. Women should see their diabetes and pregnancy health professionals as soon as possible if active pregnancy planning is continuing. The following form should be used to apply to extend access to continuous glucose monitoring for a further six months: Type 1 Diabetes; Pregnancy Planning, Extension of Access. Resources Indications for use The CGM device summary chart contains information about devices subsidised through the NDSS, their compatibility with insulin pumps and smart devices, and links to guidelines about appropriate use, including manufacturers documentation. The Therapeutic Goods Administration approves CGM devices that can be lawfully supplied in Australia and these are listed in the Australian Register of Therapeutic Goods (ARTG). By certifying Continuous Glucose Monitoring Access forms for a person, you are confirming that you are aware that not all CGM products are indicated for use in all conditions or all age groups, and that you have considered available advice about the selected device. This includes advice on the relevant ARTG listing about appropriate use for specific conditions. The CGM device summary chart contains links to the ARTG listings. Continuous glucose monitoring device summary chart This resource has information about the devices subsidised through the NDSS, their compatibility with insulin pumps and smart devices, and links to guidelines about appropriate use. Download
